Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anupama Marasini"'
Autor:
Dhan Bahadur Shrestha, MD Resident Physician, Pravash Budhathoki, MD Resident Physician, Yub Raj Sedhai, MD, Ramkaji Baniya, MD, Casey A. Cable, MD, MSc, Markos G. Kashiouris, MD, MPH, Dave L. Dixon, PharmD, Jason M. Kidd, MD, Yuvraj Adhikari, MBBS, Anupama Marasini, MBBS, Shakar Bhandari, MBBS
Publikováno v:
Current Therapeutic Research, Vol 95, Iss , Pp 100635- (2021)
ABSTRACT: Background: Patiromer and sodium zirconium cyclosilicate (SZC) are newer options for hyperkalemia treatment. This systematic review and meta-analysis were conducted to assess the safety and side effect profile of patiromer and SZC compared
Externí odkaz:
https://doaj.org/article/17dcce8f1bb24a7ca3c57c9725ff9c97
Autor:
Yuvraj Adhikari, Anupama Marasini, Nawaraj Adhikari, Laxman Dutta Paneru, Binit Upadhaya Regmi, Manita Raut
Publikováno v:
Annals of Medicine & Surgery.
Autor:
Sanjeev Shrestha, Pravash Budhathoki, Yuvraj Adhikari, Anupama Marasini, Shakar Bhandari, Wasey Ali Yadullahi Mir, Dhan B Shrestha
Publikováno v:
Cureus
Belimumab is a recombinant human IgG-1λ monoclonal antibody. It inhibits the B-cell activating factor (BAFF) and is approved for patients with systemic lupus erythematosus (SLE) older than five years with positive autoantibody. We aimed to evaluate
Autor:
Dhan Bahadur, Shrestha, Pravash, Budhathoki, Yub Raj, Sedhai, Ramkaji, Baniya, Suman, Gaire, Yuvraj, Adhikari, Anupama, Marasini, Shakar, Bhandari, Arun, Sedhain
Publikováno v:
Journal of Nepal Health Research Council. 19(2)
Hypertension, diabetes, glomerulonephritis, obesity, and family history of kidney diseases are major risk factors for chronic kidney disease. Due to the paucity of data on a national level regarding the prevalence, risk factors, and complications of
Autor:
Pravash Budhathoki, Shakar Bhandari, Markos Kashiouris, Dave L. Dixon, Jason M. Kidd, Yuvraj Adhikari, Ramkaji Baniya, Casey A. Cable, Anupama Marasini, Dhan Bahadur Shrestha, Yub Raj Sedhai
Publikováno v:
Current Therapeutic Research, Clinical and Experimental
Current Therapeutic Research, Vol 95, Iss, Pp 100635-(2021)
Current Therapeutic Research, Vol 95, Iss, Pp 100635-(2021)
Background Patiromer and sodium zirconium cyclosilicate (SZC) are newer options for hyperkalemia treatment. This systematic review and meta-analysis were conducted to assess the safety and side effect profile of patiromer and SZC compared with placeb